Comparing Bempedoic Acid/ezetimibe vs Repatha
Bempedoic acid/ezetimibe | Repatha (evolocumab) |
|
---|
Bempedoic acid/ezetimibe | Repatha (evolocumab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
The combination of bempedoic acid and ezetimibe decreases LDL-C levels by more than either drug alone. It is usually given in combination with other cholesterol-lowering treatments. Bempedoic... View more |
Prescription only
Repatha is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia and HoFH, and also to reduce the risk of cardiovascular events in adults with established... View more |
Related suggestions High Cholesterol
Cardiovascular Risk Reduction
High Cholesterol, Familial Heterozygous
|
|||||||
More about Bempedoic acid/ezetimibe | More about Repatha (evolocumab) | ||||||||
Ratings & Reviews | |||||||||
Bempedoic acid/ezetimibe has an average rating of 8.9 out of 10 from a total of 17 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 6% reported a negative effect. |
Repatha has an average rating of 5.4 out of 10 from a total of 723 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Repatha side effects |
|||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Repatha prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Nexlizet |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
22 hours |
408 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 111 drugs are known to interact with Bempedoic acid/ezetimibe:
|
A total of 3 drugs are known to interact with Repatha:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
First Approval Date | |||||||||
N/A |
August 27, 2015 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.